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Abstract
Background: We examined whether higher procedure volumes for coronary artery bypass graft
(CABG) surgery or percutaneous coronary interventions (PCI) were associated with lower costs
per patient, and if so, estimated the financial savings from regionalizing cardiac procedures.
Methods: Cost regressions with hospital-specific dummy variables measured within-hospital cost
reductions associated with increasing hospital volume. We used the regression estimates to predict
the change in total costs that would result from moving patients in low-volume hospitals to higher
volume facilities.
Results: A 10% increase in PCI procedure volume lowered costs per patient by 0.7%. For the
average hospital performing CABG in 2000, a 10% increase in volume was associated with a 2.8%
reduction in average costs. Despite these lower costs, the predicted savings from regionalizing all
PCI procedures in the sample from lower to high-volume hospitals amounted to only 1.1% of the
entire costs of performing PCI procedures for the sample in 2000. Similarly, the cost savings for
CABG were estimated to be only 3.5%.
Conclusion: Higher volumes were associated with lower costs per procedure. However, the total
potential savings from regionalizing cardiac procedures is relatively minor, and may not justify the
risks of reducing access to needed services.
Background
The number of patients who received percutaneous coro-
nary interventions (PCI) or coronary artery bypass graft
surgery (CABG) in the US has changed dramatically over
time. For example, the number of PCI procedures rose
from 377,611 to 692,621 between 1993 and 2002, an
83% increase. The number of CABG procedures rose from
312,109 in 1993 to a peak of 383,788 in 1997, before fall-
ing to 316,471 in 2002 [1].
Although the overall volume of cardiac procedures has
increased, many individual hospitals do very few of these
procedures. Several studies have found that low hospital
procedure volume is associated with higher mortality,
length of stay, and complication rates [2-7]. These results
have led to recommendations to regionalize certain pro-
cedures [8,9]. Regionalization policies that concentrate
care at a smaller number of providers should lead to
higher volumes and therefore improved patient out-
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comes, with little or no consequences for patient travel
[10].
However, little is known about the cost implications of
regionalizing care. Past studies have yielded contradictory
evidence on whether high-volume facilities perform PCI
and CABG at lower costs per patient. Some studies find
substantial cost savings associated with high procedure
volume [11,12]; while other research finds no evidence of
a volume-cost relationship [13]. This disagreement may
be due to the relatively small sample sizes and short time
periods which were used to analyze the association
between provider volume and costs. Although recommen-
dations to regionalize care are based primarily on
improvement in patient outcomes, the cost implications
are significant. If high-volume hospitals operate at lower
costs, then this policy would be one of very few interven-
tions that is not just cost-effective, but cost saving.
Our goal was to use nationally representative data to
determine whether higher cardiac procedure volumes
were associated with lower average costs per procedure
and to estimate potential cost savings from regionalizing
procedures. We studied all admissions for PCI and CABG
from a nationally representative sample of hospitals
between 1988 and 2000 to test for a volume-cost relation-
ship.
Methods
We used data from the Agency for Healthcare Research
and Quality (AHRQ) Healthcare Cost and Utilization
Project (HCUP) Nationwide Inpatient Sample (NIS) data-
base. The HCUP NIS data is a stratified random sample of
community hospitals in the United States. The dataset
annually samples 20 percent of acute care hospitals in
each of five strata (geographic region, ownership, loca-
tion, teaching status, and bedsize). The first release of the
NIS for the years 1988 to 1992 contained information
from 11 US states, and the 2000 release contains informa-
tion on over 1,000 hospitals in 28 states. On average there
are four years of data for each hospital in this study. All
inpatients with a procedure code for PCI (including
stents) (ICD-9-CM 36.0, 36.00, 36.01, 36.02, or 36.05) or
CABG (ICD-9-CM 36.1 x) in any field of the discharge
abstract were selected. The sample contained data on 439
different hospitals that performed CABG and 491 hospi-
tals that performed PCI between 1988 and 2000. Sample
weights provided in the NIS were applied during the anal-
ysis, so that the results are representative of the entire US
population who received PCI and CABG.
Hospital Volume and Costs
The NIS contains all discharge abstracts from each hospi-
tal it samples, permitting accurate counts of PCI and
CABG volume for each facility. The annual procedure vol-
ume for each hospital and year was calculated as the
number of discharges with the respective procedure code
during the calendar year of admission. Any records for
which this process revealed that the hospital performed
five or fewer procedures during the year were excluded
from the analysis.
The NIS provides total charges for each patient stay in the
hospital, which have been edited for excessively low and
high charges [14]. These charges were deflated by the All-
Urban Consumer Price Index to reflect year 2000 dollars.
The charges were then multiplied by a hospital- and year-
specific cost-to-charge ratio to reflect the costs of each
admission. A cost-to-charge ratio for each hospital and
year were derived from annual Medicare cost reports.
The Centers for Medicare and Medicaid Services (CMS)
has structured its regulations in an effort to obtain cost
and charge data in hospital cost reports that most accu-
rately reflects resource utilization. Hospital cost report
data is used to appropriately adjust prospective payment
rates for inpatient care to reflect resource utilization. As
stated in the Code of Federal Regulations: "Adequate cost
information must be obtained from the provider's records
to support payments made for services furnished to bene-
ficiaries. The requirement of adequacy of data implies that
the data be accurate and in sufficient detail to accomplish
the purposes for which it is intended [15]." In particular
CMS relies on the cost reports to determine the resource
utilization of Medicare beneficiaries versus other hospital
patients: "Total allowable costs of a provider will be
apportioned between program beneficiaries and other
patients so that the share borne by the program is based
upon actual services received by program beneficiaries."
CMS relies in part on the charges reported in hospital cost
reports to determine Medicare patients' costs relative to all
patients. For example, the ratio of Medicare patients'
charges to all patients' charges is used to apportion ancil-
lary department costs to revenue-generating departments.
CMS has adopted this approach, because "An increasing
number of third-party purchasers who pay for services on
the basis of cost are developing methods that utilize
charges to measure the amount of services for which they
have responsibility for payment."
Patients with costs below $1,000, which were likely to
reflect coding error, were removed from the sample. Six
states in the NIS did not provide hospital identification
codes which are needed to merge the NIS with Medicare
data, and therefore hospitals in these states were excluded
from the analysis.Cost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
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Other Study Variables
Age, sex, race, AMI, urgent or emergency admission, and
transfer from another hospital were included as explana-
tory variables in cost regressions. Indicator variables are
also included for the individual comorbidities that com-
prise the Charlson comorbidity index which are: prior
AMI, peripheral vascular disease, dementia, chronic
obstructive pulmonary disease, rheumatologic disease,
liver disease (mild), liver disease (moderate/severe), dia-
betes (mild/moderate), diabetes with complications, kid-
ney disease, cancer, and metastatic solid tumor. These
conditions were coded based on the Dartmouth-Mani-
toba mapping of the Charlson comorbidity index to ICD-
9-CM codes [16]. This mapping recognizes that certain
diagnostic and procedure codes may represent complica-
tions when they appear on the index discharge abstract (as
opposed to abstracts from previous admissions). There-
fore, the mapping specifies a subset of ICD-9-CM codes
for each condition that excludes potential complications
if one only has access to discharge records from the cur-
rent admission, as we do in this study.
Indicator variables for patients who received multivessel
PCI or a stent were included in the cost regressions for PCI
patients. We did not include indicator variables for other
procedures, such as CABG for patients undergoing PCI.
Higher incidence of emergency bypass surgery after PCI
has been found in low-volume hospitals [17,18]. There-
fore, if patients in low-volume hospitals require more pro-
cedures as a result of complications, the regressions
attribute the resulting costs to volume.
Statistical Analysis
We defined low volume PCI as fewer than 200 procedures,
medium volume as 200 to 399 procedures, and high vol-
ume as 400+ procedures per year. We defined low volume
CABG as fewer than 200 surgeries, medium volume as
200 to 449 surgeries, and high volume as 450+ surgeries
per year. The cutoff point for high volume hospitals was
based on hospital referral guidelines published by the
Leapfrog group. Medium volume hospitals were deter-
mined by consulting minimum institutional volume rec-
ommendations published in the ACC/AHA guidelines as
well as past studies [4,8,19-22].
Mean costs are reported for three time periods: 1988–
1991, 1992–1996, and 1997–2000. We also report the
percentage of patients who are 85 years and over, and the
proportion of patients who underwent stent insertion by
hospital volume and time period. We hypothesized that
both older age and stent insertion contribute to higher
costs.
The unit of observation in the regressions is the patient.
We estimate separate cost regressions for PCI and CABG.
The distribution of patient costs for both CABG and PCI is
skewed due to extremely high costs for a small number of
outliers. Therefore, the natural logarithm of patient cost
was used as the dependent variable in each case in order
to reduce the sensitivity of the estimates to extreme obser-
vations. In addition to making the estimates more consist-
ent with classical linear model assumptions, the log
model allows one to interpret the coefficient estimates as
percentage changes in costs as a function of unit increases
in the explanatory variables [23].
For both PCI and CABG, there was only one regression for
which the association between costs and volume was pre-
cisely estimated, and for which alternative specifications
(such as adding the square and the cube of hospital vol-
ume) yielded no additional explanatory power [24]. The
natural log of hospital volume provided the best fit for
modeling PCI costs. In contrast, a cubic polynomial of
hospital volume in levels provided the best fit for the rela-
tion between hospital volume and costs for CABG proce-
dures.
The cost regressions are estimated including dummy vari-
ables for each hospital in the sample. This "fixed effects"
approach controls for unobservable hospital characteris-
tics that may confound the relationship between volume
and costs [25]. For example, one may be concerned that
some hospitals may have higher quality facilities that
attract more patients, but are also more costly. By includ-
ing a dummy variable for each hospital, one controls for
these systematic differences across hospitals. The regres-
sions therefore provide an estimate of the expected change
in costs resulting from a within-hospital increase in proce-
dure volume. The hospital-specific dummy variables will
also capture the effects of any observed hospital character-
istics which are constant throughout the sample period,
such as teaching status. Therefore, the regression coeffi-
cients will measure the average size of the relationship
between volume and costs over all teaching and non-
teaching hospitals in the US This approach is the most rea-
sonable one for a nationwide policy simulation. All
regressions were estimated in Stata 8.0, and standard
errors were adjusted for the clustering of patients at the
hospital level.
Estimates based on within-hospital changes in procedure
volume can be used to predict the effects of alternative
regionalization policies. For a log (cost) regression where
hospital volume is expressed in natural logs, the coeffi-
cient on volume provides the percentage increase in costs
resulting from a one percentage point increase in hospital
volume. To compute a consistent estimate of the percent
change in costs for a log(cost) regression where hospital
volume is specified in levels and polynomials of volume,
we first multiplied each polynomial in volume in theCost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
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regression by its respective coefficient. We then took the
exponential of the sum of these products, subtracted 1,
and multiplied the resulting number by 100 [23].
Because the NIS sampled only 20 percent of hospitals in
the participating states, one cannot predict the results of
closing low-volume hospitals and referring the patients in
these hospitals to the geographically closest high-volume
hospital. Instead, we used the regression estimates to pre-
dict the change in total costs that would result from mov-
ing patients in low-volume hospitals to representative
higher volume hospitals. For both PCI and CABG, we
identified all patients treated in low-volume hospitals in
the last year of the sample, 2000. We then predicted the
change in costs that would result if they had instead been
treated in a "typical" higher volume hospital, defined as a
facility with the median procedure volume of all medium
and high volume hospitals in the sample in 2000. We also
predicted the change in costs that would result if all
patients treated in low and medium volume hospitals
were instead treated in a hospital with the median size of
all high-volume hospitals in 2000. Simulations of the
change in costs resulting from closing low-volume hospi-
tals required converting regression estimates so that they
reflected an unbiased estimate of costs rather than log
(costs) [23].
Results
The NIS contained data on 1,046,630 PCI admissions and
828,148 admissions for CABG. Six states in the NIS did
not provide hospital identification codes which are
needed to merge the NIS with Medicare data. For this rea-
son, we excluded 96,791 PCI admissions and 68,254
CABG admissions from the analysis. In addition, 19,503
PCI records and 15,726 CABG records were missing infor-
mation on charges. There were 9 PCI admissions and 12
CABG admissions that were missing information on
patient gender. Our regressions were based on the remain-
ing 930,327 PCI patients and 744,156 CABG patients.
These data represent 98 percent of the patients in the
states which reported hospital identifiers.
Table 1 illustrates the distribution of both hospitals and
patients by hospital procedure volume. The data reveal a
gradual increase in high-volume hospitals and a greater
propensity for patients to be treated in high-volume hos-
pitals over time. However, by 1997–2000 approximately
one quarter of hospitals performing PCI and/or CABG in
the sample were still considered to be low-volume facili-
ties. Because by definition these facilities treated fewer
patients, less than 10 percent of patients were treated in
low-volume facilities for most of the sample period. Yet
by the last time period, 1997–2000, 16.1 percent of PCI
patients and 37.4 percent of CABG patients were still
being treated in hospitals which did not meet the Leapfrog
Group's volume-based standard of care.
Average Costs per Procedure
Table 2 provides information on the average costs of care
for patients who received either PCI or CABG by hospital
volume and time period. The average cost in 2000 dollars
of performing PCI declined from $12,451 in 1988–1991
to $11,363 in 1997–2000. The average cost of performing
CABG declined even further over the sample period, from
$30,733 in 1988–1991 to $24,001 in 1997–2000. This
pattern is consistent with previous studies reporting
declining real costs of performing PCI and CABG between
1984 and 1994 [26]. Within each time period there is also
an association between higher hospital procedure volume
and lower costs per patient. Table 2 indicates that the per-
centage of patients age 85 years or older rose throughout
the sample for both procedures. The table also reveals the
dramatic rise in stent use over the sample period, as well
Table 1: Distribution and total number of hospitals and patients* by hospital volume and year
PCI CABG
Hospital Volume Hospital Volume
< 200 200–399 400+ Total # < 200 200–449 450+ Total #
Hospitals
1988–1991 41.0% 32.7% 26.3% 806 36.0% 42.1% 21.9% 773
1992–1996† 25.5% 28.0% 46.5% 874† 28.4% 42.5% 29.1% 829†
1997–2000 24.8% 22.4% 52.8% 841 27.6% 39.8% 32.6% 753
Patients
1998–1991 12.9% 29.7% 57.4% 1.03 million 11.3% 39.2% 49.4% 1.06 million
1992–1996† 5.4% 17.5% 77.2% 2.03 million† 7.9% 33.8% 58.2% 1.67 million†
1997–2000 4.2% 11.9% 83.9% 1.90 million 7.9% 29.5% 62.6% 1.27 million
*The data are weighted so that they are representative of the US population.
†The middle time period is based on five years of data; other time periods contain data from four years.Cost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
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as a positive correlation between hospital volume and
stent use.
Each 10 percent increase in a hospital's PCI procedure vol-
ume reduces average costs per patient by 0.7 percentage
points (p = 0.012), controlling for year, patient character-
istics, and hospital fixed effects (Table 3). Mean PCI pro-
cedure volume over the sample period rose by 139 percent
(from 255 to 610) between 1988 and 2000. This magni-
tude of increase in procedure volume is predicted to lower
average costs per patient by 9.7 percent.
The mean CABG hospital procedure volume in the year
2000 in our sample is 405 procedures. A 10 percent
increase in CABG volume (41 procedures) is predicted to
reduce costs per patient by 2.8 percent. Mean CABG pro-
cedure volume over the sample period rose by 82 proce-
dures (from 323 to 405) between 1988 and 2000. This
magnitude of increase is predicted to lower average costs
per inpatient stay by 5.2 percent. From a baseline cost of
$23,910 (the average cost per CABG patient in 2000), a
5.2 percent reduction in costs would equal $1,243.
To determine whether the negative association between
volume and costs was consistent for the thirteen years in
the study, we re-estimated the regressions in Table 3
including interactions between procedure volume and the
two later time periods (1992 to 1996 and 1997 to 2000).
For both PCI and CABG, the interaction terms were insig-
nificant, with the lowest p-value being equal to 0.221.
Estimated Cost Savings of Regionalization Policies
We used the regression estimates to predict the change in
costs that would result from eliminating PCI and CABG in
low-volume hospitals and moving these patients instead
to higher volume hospitals (Figure 1). A total of 17,236
PCI patients out of 509,491 (3.4%) were treated in low-
volume hospitals in the year 2000. Among medium and
high-volume hospitals in the sample in 2000, the median
PCI procedure volume was 539. If these 17,236 patients
had instead been treated in a hospital which performed
539 PCI procedures per year, the regression estimates
indicate that the total costs of caring for these patients
would be lowered by $22.1 million.
Altogether 68,020 PCI patients (13.4%) in the year 2000
were treated in low or medium volume hospitals. If these
patients had instead been treated in the median high-vol-
ume hospital for 2000, which performed 708 procedures,
total costs were estimated to be lowered by $63.1 million.
The total cost of performing all PCI procedures in the sam-
ple for the year 2000 equaled $5.8 billion. Therefore, the
predicted savings from regionalizing all PCI procedures to
high-volume hospitals amounted to 1.1% of the entire
costs of performing the procedure in 2000.
Similarly, if the 25,646 patients (8.7%) in low-volume
hospitals had instead been treated in a hospital which per-
formed 400 CABG procedures per year, the regression esti-
mates suggest that total costs would be lowered by $66.4
million; and if patients treated at both low- and medium-
volume sites (38.0%) had instead been treated in a hospi-
tal with the median high-volume procedure load of 710
procedures in 2000, the total costs of caring for these
patients were estimated to be lowered by $252.8 million.
The total cost of performing all CABG surgeries for the
year 2000 equaled $7.1 billion. Therefore, the predicted
savings from regionalizing all CABG procedures to high-
volume hospitals amounted to only 3.5% of the entire
costs of performing the procedure in 2000.
Table 2: Trends in average costs and patient characteristics by hospital procedure and volume 1998–2000
PCI CABG
Hospital Volume Hospital Volume
< 200 200–399 400+ Total # < 200 200–449 450+ Total #
Cost*
1988–1991 $13,599 $12,787 $12,019 $12,451 $37,219 $30,704 $29,271 $30,733
1992–1996 $13,592 $13,043 $11,617 $11,972 $33,241 $28,035 $26,252 $27,409
1997–2000 $12,606 $12,563 $11,130 $11,363 $26,862 $24,293 $23,500 $24,001
Age 85+, %
1988–1991 0.9 1.0 0.9 0.9 0.7 0.8 0.7 0.7
1992–1996 1.6 1.6 1.6 1.6 1.1 1.2 1.2 1.2
1997–2000 3.0 2.9 2.8 2.8 1.8 1.8 2.0 1.9
Stent, %
1 9 8 8 – 1 9 9 1 0000
1992–1996 6.4 7.9 11.4 10.5
1997–2000 67.4 73.3 76.5 75.8
*Average cost per procedure in year 2000 dollars.Cost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
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The number of states in the HCUP increased from 11 to
28 over the sample period [27], so that our estimates may
have been affected by sample composition. We re-esti-
mated the cost regressions restricting the sample to hospi-
tals in the 11 states which were represented in all 13 years
of the sample. The magnitude of the coefficient estimates
remained virtually the same, although the precision of the
estimates decreased slightly. We also repeated the regres-
sion analysis without the NIS sample weights, which were
constructed by the AHRQ to yield results which are repre-
sentative of the entire US population. The differences in
results, if at all, were in the third decimal place of the coef-
ficients reported in Table 3. The minimal differences sug-
gest that the sample is indeed representative of the
relationship between volume and costs in the nation as a
whole.
Discussion
Using nationally representative data from the years 1988–
2000, we determined that higher cardiac procedure vol-
umes were associated with lower average costs per proce-
dure. This finding was robust and consistent over the
thirteen years of our study. Surprisingly, despite these
lower average costs, the absolute magnitude of cost sav-
ings that could be achieved was relatively small. For exam-
ple, we found that the predicted savings from
regionalizing all PCI procedures in the sample to high-
volume hospitals amounted to only 1.1% of the entire
Table 3: Regression estimates of determinants of log(average costs per procedure)
PCI CABG
Coefficient CI Coefficient CI
Log(volume) -0.07 (-0.124– -0.016)
Volume -0.0007 (-0.0012– -0.0002)
Volume2 6.62E-07 (1.26E-07– 1.20E-06)
Volume3 -1.79E-10 (-3.37E-10– -2.16E-11)
Sample Size 930,327 744,156
Regressions also include year dummy variables (1989 to 2000), indicators for age (65–69, 70–74, 80–84, 85 years), female, black race, AMI, urgent 
or emergency admission, transfer from another hospital, the individual components of the Charlson comorbidity index, multivessel PCI or stent use 
for PCI patients, and a dummy variable for each hospital in the sample.
Actual costs and predicted results of closing lower volume hospitals and redirecting patients to higher volume facilities in 2000 Figure 1
Actual costs and predicted results of closing lower volume hospitals and redirecting patients to higher volume 
facilities in 2000. a Predictions of total costs and patients affected if patients in low-volume hospitals were instead treated in 
a hospital with the median procedure volume of medium and high-volume hospitals in year 2000. b Predictions of total costs 
and patients affected if patients in low and medium-volume hospitals were instead treated in a hospital with the median proce-
dure volume of high-volume hospitals in year 2000.
5.717 billion
5.759 billion 5.780 billion
3.4%
13.4%
5.0
5.2
5.4
5.6
5.8
Actual Close Low-Volume
Hospitals
Close Low &
Medium-Volume
Hospitals
PCI
$ (Billion)
0%
20%
40%
60%
80%
100%
Percent
6.806 billion
6.993 billion
7.059 billion
38.0%
8.7%
5.0
5.7
6.4
7.1
Actual Close Low-Volume
Hospitals
Close Low &
Medium-Volume
Hospitals
CABG
$ (Billion)
0%
20%
40%
60%
80%
100%
Percent
Costs
Percent of all patients to be redirectedCost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
Page 7 of 9
(page number not for citation purposes)
costs of performing PCI procedures for the sample in that
year. Similarly, the cost savings for CABG were estimated
to be only 3.5%.
A handful of other studies have assessed the relationship
between volume and costs for CABG and PCI. Although
two studies found a negative association between volume
and costs for PCI [11,12], one study of CABG found no
association between volume and costs [13]. However, the
latter study was based on only twelve hospitals. In addi-
tion, past studies of the volume-cost relationship ana-
lyzed data for 2 years at most, making it difficult to
determine if the findings were robust and consistent
across years. One study used Medicare data [11], making
the generalization of findings to the non-Medicare popu-
lation of potential concern. Past studies of PCI or CABG
volume and costs were cross-sectional in nature. These
studies measured the relationship between volume and
costs by comparing costs across hospitals that differed in
size over a one to two year time period. Thus, the associa-
tion between volume and costs could be confounded by
other attributes that differ systematically across hospitals,
such as the specific technologies used to perform PCI and
CABG, the costs of health care workers in the local labor
market, or differences in patient casemix that generally are
not reported in administrative databases.
We overcame these methodological problems in several
ways. First, we used a nationally representative sample of
hospitals, and we included all procedures performed at
sampled hospitals. We studied costs over 13 years to
ensure that our findings were consistent and robust. In
order to examine how costs change within a given hospi-
tal as its volume increased over time, we used a fixed
effects model. Inclusion of a dummy variable for each
hospital controls for systematic, unobserved differences
across hospitals, such as differences in technology, labor
costs, patient population, or the manner in which finan-
cial information in cost-to-charge ratios is reported. The
regression estimates yield the within-hospital change in
costs associated with within-hospital increases in volume
over time. We believe that these methods overcome many
of the problems with prior studies and yield appropriate
measures to predict the potential cost impact of regional-
ization.
Why did we find only limited potential savings, despite
lower average costs per procedure with higher volume?
The limited savings are because the number of patients
being treated in low-volume hospitals has fallen over
time. For example, only 17,236 PCI patients out of
509,491 were treated in low-volume hospitals in the year
2000. Our findings confirm speculation that volume-
based referral strategies would not greatly reduce direct
health care costs [28]. Adding capacity (i.e. operating
rooms and beds) at high-volume referral hospitals could
lead to higher costs in the short term. Also, administrative
costs associated with transferring patients and their
records to high-volume hospitals would be created. Lastly,
high-volume hospitals may have more market power, per-
haps leading them to raise their charges.
Of course, the primary motivation for regionalization pol-
icies has not been cost savings, but improving patient out-
comes. Several studies have found that low hospital
procedure volume is associated with higher mortality,
readmission, and complication rates [8,20,29]. These
results have led to recommendations that certain proce-
dures should be regionalized [8]. Concentrating care
through regionalization policies at a smaller number of
providers should lead to higher volumes and therefore
improved patient outcomes.
One limitation of our study is that we were not able to
estimate the potential years of life gained in the sample by
regionalization. We also may not have ascertained all PCI
procedures in the later years of the study, as more PCI pro-
cedures were performed in the outpatient setting. How-
ever, we sought to study the effect of hospital volume on
inpatient costs. It is possible that expertise gained from
performing additional outpatient procedures has a "spill-
over" effect, leading to reduced inpatient PCI costs as well.
In this case, inpatient PCI volume yields an underestimate
of total procedure volume, and our regressions overesti-
mate the association between increased procedure vol-
ume and lower costs. If so, the estimated cost savings from
regionalization may be even smaller.
Despite the efforts by CMS to obtain accurate cost data,
one must acknowledge the weaknesses of using account-
ing data to reflect economic costs. For example, hospitals
have discretion in the order in which they allocate the
costs of non-revenue producing centers to service centers,
which can change the relative costs of each service center.
In addition, CMS gives specific instructions on the cost
bases for allocating overhead costs (e.g. square footage for
maintenance and repairs, or patient days for laundry serv-
ices). These cost bases may not accurately reflect the actual
balance of resource utilization across departments. Never-
theless, we have no reason to believe that accounting costs
would be systematically higher (or lower) than economic
costs for high volume versus low volume hospitals. There-
fore, these errors are not likely to bias our regression esti-
mates.
The ratio of cost to charges for each hospital as a whole
may not provide an accurate correction for the cost of car-
diac procedures at each hospital [30]. Measurement error
in the dependent variable costs could lead to larger error
variance when estimating the association between volumeCost Effectiveness and Resource Allocation 2007, 5:7 http://www.resource-allocation.com/content/5/1/7
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and costs, which would lower the chance of finding a sig-
nificant association between these two variables. How-
ever, even with the potential for measurement error, we
precisely estimate an association between higher proce-
dure volume and lower unit costs. Moreover, past studies
which have tried to adjust charges using department-level
information have encountered wide variations in missing
data and extreme outlier values across departments
[31,32]. In addition, costs computed using an aggregate
hospital cost-to-charge ratios were found generally to be
within 10 percent of costs obtained from department-
level cost data [33]. Another study found that profitability
estimates (which require cost data) based on aggregate
hospital cost-to-charge ratios were identical to estimates
based on department-level data for Medicare and pri-
vately insured patients, and differed by only four percent-
age points for Medicaid patients [32]. Therefore,
discrepancies between hospital-wide and department-spe-
cific cost-to-charge ratios are not likely to explain the dif-
ferences in costs between low and high-volume hospitals
identified in this study. Even if there were a large bias in
our cost estimates–for example–if we underestimated the
cost savings from regionalization by a factor of two, these
cost savings would still be extremely small relative to the
total costs of PCI and CABG in the US Further, several dis-
ease-specific cost analyses have relied on aggregate hospi-
tal cost-to-charge ratios rather than department-level data
[34-36]. As one of these studies notes, analysis of a spe-
cific treatment with large fixed costs such as PCI and
CABG yields a more homogeneous hospital sample,
which mitigates any bias created by the use of hospital-
level data [36]. In the absence of department-level finan-
cial data across multiple parts of the country and for all
age groups, hospital-level cost-to-charge ratios are the best
possible information source for making region-wide pol-
icy recommendations.
The hospital fixed effects control only for unobservable
characteristics which are constant over time for a given
hospital. It is possible that there are unobservable changes
over time for a hospital that both increase its cardiac pro-
cedure volume and make the facility more efficient in the
provision of care. Such unobservable changes would
imply that we have underestimated the cost savings asso-
ciated with regionalization. However, we are unaware of
any literature identifying hospital ventures that have been
associated with both lower costs and increased procedure
volume for cardiac care. Unless such unobservable actions
are widespread in our sample, they are unlikely to sub-
stantially bias our results.
Our dataset lacks information on physician costs. We are
unaware of any studies which analyze the relation
between hospital or physician procedure volume and
physician costs. Even if higher hospital volume is associ-
ated with lower physician costs, the small fraction of
patients now being treated in low-volume hospitals is still
likely to lead to only limited cost savings under regionali-
zation.
Conclusion
As the costs of cardiac care continue to grow, clinicians
and policy makers will be searching for solutions to con-
trol expenditures. With the presence of economies of scale
in complex procedures, regionalization will be a likely
candidate as a policy instrument. We find that regionali-
zation based on recommendations that were made to
reduce mortality will not be enough to significantly
reduce health care costs. Also, due to limited availability
of high-volume hospitals in certain geographic regions,
regionalization policies may not always be feasible. Other
studies have suggested that regionalization policies may
produce underuse of clinically necessary cardiac proce-
dures [37]. Therefore, regionalization policies require
careful implementation to ensure that their potential ben-
efits on patient outcome and costs are not outweighed by
the hidden costs of barriers to access and underuse of
needed services.
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